December 14, 2017 – Inversago Pharma’s CEO François Ravenelle will attend Biotech Showcase, January 8-10th, 2018 in San Francisco, CA.
September 02, 2017 – Inversago Pharma’s CEO François Ravenelle will attend RESI Boston event on September 26th. Come and meet with us!
April 26, 2016 - Inversago Pharma announces the execution of license agreement with US NIH's CB1 inverse agonist techno including MRI-1867.
October 28, 2015 - National Institutes of Health Notice on Prospective Grant of Exclusive License